Artha Sootra - Company Dashboard

Governance Classic Home

Marksans Pharma LtdPharmaceuticalsINE750C01026Consolidated₹301.15-13.95 (-4.43%)

Valuation

Market Cap₹13.67K Cr

TTM PE24.41x

Forward PE22.94x

PEG2.93

Book Value₹66.71

P/B4.52x

TTM EPS₹12.36

Fwd EPS₹13.15

TTM Revenue₹3.39K Cr

TTM PAT₹565.66 Cr

TTM EBITDA₹783.49 Cr

TTM EBIT₹677.90 Cr

Last Qtr PAT₹143.53 Cr

Last Qtr EBITDA₹214.29 Cr

Last Qtr EBIT₹182.18 Cr

Profitability

ROE18.71%

ROCE23.07%

TTM NPM16.68%

TTM EBITDA %23.10%

Curr OPM14.98%

Last OPM18.40%

Curr NPM—

Last NPM—

Curr EPS₹3.12

Last EPS₹3.47

Balance sheet

Equity₹45.32 Cr

Reserve₹2.98K Cr

Total Debt₹343.38 Cr

D/E0.11x

Interest %4.76%

Curr Interest₹6.83 Cr

Price / range

Close₹301.65

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D-4.33%

1W-1.33%

1M-7.40%

3M+12.14%

6M+59.47%

1Y+61.53%

2Y+5.05%

3Y+167.78%

5Y+348.55%

Diwali+67.82%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1773.40	₹4.25L Cr	38.81	12.31%
DIVISLAB	10037.50	₹2.66L Cr	91.08	17.45%
TORNTPHARM	4738.50	₹1.60L Cr	77.77	11.42%
LAURUSLABS	2323.80	₹1.25L Cr	93.63	21.98%
ZYDUSLIFE	1188.10	₹1.20L Cr	28.53	15.79%
DRREDDY	1374.00	₹1.15L Cr	40.89	7.11%
CIPLA	1402.00	₹1.13L Cr	39.09	8.06%
MANKIND	2537.90	₹1.05L Cr	46.71	12.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	313.80-2.1%	321.19	361.57	339.73	320.44	1,341.48
Other Income	57.24	17.47	27.48	15.86	58.19	103.53
Total Income	371.05-2.0%	338.66	389.05	355.59	378.63	1,445.01
Interest	0.34	0.34	0.35	0.36	0.32	1.33
Expenditure	-270.83-5.3%	-248.20	-264.69	-273.47	-257.14	-1,053.47
PBDT	0	0	0	0	0	0
EBITDA	52.36-27.4%	82.11	105.99	75.45	72.08	323.57
Depreciation	-9.05	-8.78	-8.76	-8.83	-8.46	-34.23
EBIT	43.31-31.9%	73.33	97.23	66.62	63.62	289.34
PBT	100.21-17.5%	90.46	124.36	82.12	121.49	391.54
Tax	-14.67	-21.42	-32.44	-21.20	-21.69	-90.85
Equity	45.32	45.32	45.32	45.32	0	45.32
OPM	27.01	26.71	31.97	23.09	37.91	27.10
Net Profit	85.54-14.3%	69.04	91.92	60.91	99.81	300.70
NPM	23.05	20.39	23.63	17.13	31.15	20.81
EPS	1.89-14.1%	1.52	2.03	1.34	2.20	6.64

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	1,341.48+14.2%	1,174.37+37.6%	853.27+30.2%	655.20-0.5%	658.29+9.8%	599.55
Other Income	103.53	69.83	62.07	60.48	42.25	31.16
Total Income	1,445.01+16.1%	1,244.21+35.9%	915.35+27.9%	715.69+2.2%	700.54+11.1%	630.70
Expenditure	-1,053.47-5.2%	-1,000.95-34.6%	-743.45-27.4%	-583.65-3.1%	-566.03-11.8%	-506.37
Interest	-1.33	-1.17	-0.99	-3.61	-3.80	-5.35
PBDT	0	0	0	0	0	0
EBITDA	323.57+58.6%	204.04+45.8%	139.94+52.3%	91.90-19.2%	113.72+0.0%	113.72
Depreciation	-34.23	-29.45	-29.13	-16.74	-17.66	-15.19
EBIT	289.34+65.7%	174.59+57.6%	110.81+47.4%	75.16-21.8%	96.06-2.5%	98.53
PBT	391.54+61.0%	243.26+41.5%	171.89+30.2%	132.04-1.8%	134.51+8.2%	124.33
Tax	-90.85	-54.99	-38.13	-29.17	-30.52	-25.95
Equity	45.32	45.32	0	0	0	0
OPM (%)	27.10	19.55	19.00	18.00	19.00	20.00
Net Profit	300.70+59.7%	188.27+40.8%	133.76+30.0%	102.87-1.1%	103.99+5.7%	98.38
NPM (%)	20.81	15.13	15.00	14.00	15.00	16.00
EPS (Rs)	6.64+60.0%	4.15+40.7%	2.95+19.0%	2.48-2.4%	2.54+5.8%	2.40
CEPS	6.63	4.15	2.95	2.48	2.54	2.40

Metric	Sep-26	Jun-26	Mar-26	Dec-25	Sep-25	FY25-26
Revenue	940.17+30.5%	840.80	856.11	754.43	720.41	2,950.94
Other Income	18.15	25.40	35.17	20.14	21.57	82.53
Total Income	958.32+29.2%	866.20	891.29	774.57	741.98	3,033.47
Interest	6.83	7	6.31	5.94	5.82	24.13
Expenditure	-764.82-25.7%	-659.63	-691.29	-623.95	-608.65	-2,472.92
PBDT	0	0	0	0	0	0
EBITDA	214.29+48.3%	213.03	195.42	160.75	144.50	600.78
Depreciation	-32.11	-24.86	-24.29	-24.33	-26.92	-98.63
EBIT	182.18+54.9%	188.17	171.13	136.42	117.58	502.15
PBT	193.50+45.1%	206.57	200	150.62	133.33	560.56
Tax	-49.98	-47.16	-50.97	-36.93	-34.20	-140.49
Equity	45.32	45.32	45.32	0	0	45.32
OPM	20.19	23.85	22.44	19.45	17.97	18.48
Net Profit	143.53+44.8%	159.41	149.03	113.69	99.14	420.06
NPM	14.98	18.40	16.72	14.68	13.36	13.85
EPS	3.12+43.8%	3.47	3.27	2.50	2.17	9.22

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	2,950.94+1025.1%	262.28-88.0%	2,177.41+17.6%	1,852.14+24.2%	1,490.84+8.3%	1,376.18
Other Income	82.53	7.04	50.42	59.31	41.85	6.69
Total Income	3,033.47+1026.3%	269.32-87.9%	2,227.83+16.6%	1,911.45+24.7%	1,532.69+10.8%	1,382.88
Expenditure	-2,472.92-1029.5%	-218.93+87.9%	-1,804.30-14.6%	-1,573.80-22.5%	-1,285.18-18.9%	-1,080.71
Interest	-24.13	-1.17	-11.20	-9.13	-8.45	-7.99
PBDT	0	0	0	0	0	0
EBITDA	600.78+1036.5%	52.86-88.5%	458.58+35.1%	339.32+31.1%	258.89-23.8%	339.61
Depreciation	-98.63	-8.34	-74.27	-51.85	-44.78	-36.15
EBIT	502.15+1027.9%	44.52-88.4%	384.31+33.7%	287.47+34.3%	214.11-29.4%	303.46
PBT	560.56+1012.2%	50.40-88.1%	423.53+25.4%	337.65+36.4%	247.51-18.1%	302.16
Tax	-140.49	-12.13	-108.63	-72.33	-60.70	-63.63
Equity	45.32	4.53	0	0	0	0
OPM (%)	18.48	18.71	19.01	17.66	16.15	21.85
Net Profit	420.06+997.9%	38.26-87.9%	314.90+18.7%	265.32+42.0%	186.81-21.7%	238.54
NPM (%)	13.85	14.21	14.13	13.88	12.19	17.25
EPS (Rs)	9.22+9.8%	8.40+21.4%	6.92+8.0%	6.41+42.1%	4.51-21.7%	5.76
CEPS	9.22	8.40	6.92	6.41	4.51	5.76

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	0.9	20 Aug 2026
2025	Final Dividend	0.8	01 Aug 2025
2024	Final Dividend	0.6	17 Sep 2024
2023	Final Dividend	0.5	07 Jun 2023
2022	Final Dividend	0.25	19 Aug 2022
2021	Final Dividend	0.25	15 Sep 2021
2020	Final Dividend	0.1	22 Sep 2020
2019	Final Dividend	0.05	19 Sep 2019
2018	Final Dividend	0.05	19 Sep 2018
2017	Final Dividend	0.05	19 Sep 2017
2016	Final Dividend	0.12	22 Sep 2016
2015	Final Dividend	0.12	23 Sep 2015
2014	Final Dividend	0.1	18 Sep 2014

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split